AEON Global Health Recognized as Leaders in Cancer Genomics and Receive GHP Award for Excellence in Toxicology Diagnostics
GHP Announces the 2019 Biotechnology Awards Winners GAINESVILLE, GA – March 08 , 2019 – AEON Global Health Corp. (OTC QB: AGHC), a leading healthcare company was recognized as “Leaders in Cancer Genomics Diagnostics 2019” and received the “GHP Award for Excellence in Toxicology Diagnostics” as announced by the UK-based GHP Magazine. GHP
Read More